CLEAR LABELS Act
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, CLEAR LABELS Act, changes federal law or congressional policy affecting importers, exporters, and commercial firms. The main policy domain is Trade, Healthcare, Agriculture.
Who Benefits and How
importers, exporters, and commercial firms may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies, importers, exporters, and commercial firms may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section S1: 1. Short title This Act may be cited as the Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act or the...
- Section idd7b7c7b4d2e3473eb976eef8adf16551: 2. Require drug labeling to include original manufacturer and supply chain information Section 502(b) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C....
- Section id0eee505bb2c24601b7f2334be946e1fa: 3. Exemption from customs country of origin marking requirement Section 304 of the Tariff Act of 1930 (19 U.S.C. 1304) is amended by adding at the end the...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
This bill, CLEAR LABELS Act, changes federal law or congressional policy affecting importers, exporters, and commercial firms.
Key Policy Areas
Trade, Healthcare, Agriculture
Primary Purpose
This bill, CLEAR LABELS Act, changes federal law or congressional policy affecting importers, exporters, and commercial firms.
Policy Domains
Whole bill
Identified Gains
- importers, exporters, and commercial firms
Identified Costs
- federal implementing agencies
- importers, exporters, and commercial firms
Sponsors
Legislative Progress
In CommitteeCommittee on Health, Education, Labor, and Pensions. Hearings held.
Read twice and referred to the Committee on Health, Education, …
Introduced in Senate
Mr. Scott of Florida (for himself, Mrs. Gillibrand, Mr. Tuberville, …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "the_secretary"
- → The Secretary identified in the operative section
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology